Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ALEMBIC PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ALEMBIC PHARMA DR. DATSONS LABS/
ALEMBIC PHARMA
 
P/E (TTM) x -10.9 19.5 - View Chart
P/BV x 0.2 7.5 2.2% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 DR. DATSONS LABS   ALEMBIC PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ALEMBIC PHARMA
Mar-19
DR. DATSONS LABS/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs126664 18.9%   
Low Rs31412 7.5%   
Sales per share (Unadj.) Rs133.0208.7 63.7%  
Earnings per share (Unadj.) Rs0.231.0 0.5%  
Cash flow per share (Unadj.) Rs6.637.1 17.8%  
Dividends per share (Unadj.) Rs05.50 0.0%  
Dividend yield (eoy) %01.0 0.0%  
Book value per share (Unadj.) Rs128.8144.2 89.3%  
Shares outstanding (eoy) m31.66188.52 16.8%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.62.6 22.8%   
Avg P/E ratio x516.117.4 2,972.6%  
P/CF ratio (eoy) x11.814.5 81.7%  
Price / Book Value ratio x0.63.7 16.3%  
Dividend payout %017.7 0.0%   
Avg Mkt Cap Rs m2,477101,461 2.4%   
No. of employees `000NANA-   
Total wages/salary Rs m567,467 0.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,21139,347 10.7%  
Other income Rs m7994 83.9%   
Total revenues Rs m4,28939,441 10.9%   
Gross profit Rs m5698,736 6.5%  
Depreciation Rs m2041,152 17.7%   
Interest Rs m430184 233.7%   
Profit before tax Rs m137,493 0.2%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m-2-93 1.9%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,568 0.4%   
Profit after tax Rs m55,844 0.1%  
Gross profit margin %13.522.2 60.8%  
Effective tax rate %48.020.9 229.6%   
Net profit margin %0.114.9 0.8%  
BALANCE SHEET DATA
Current assets Rs m6,85219,577 35.0%   
Current liabilities Rs m6,71114,896 45.0%   
Net working cap to sales %3.311.9 28.1%  
Current ratio x1.01.3 77.7%  
Inventory Days Days16190 179.2%  
Debtors Days Days31845 702.2%  
Net fixed assets Rs m3,67327,097 13.6%   
Share capital Rs m317377 84.0%   
"Free" reserves Rs m3,76126,811 14.0%   
Net worth Rs m4,07827,188 15.0%   
Long term debt Rs m1,6714,993 33.5%   
Total assets Rs m12,63347,778 26.4%  
Interest coverage x1.041.7 2.5%   
Debt to equity ratio x0.40.2 223.1%  
Sales to assets ratio x0.30.8 40.5%   
Return on assets %3.412.6 27.3%  
Return on equity %0.121.5 0.5%  
Return on capital %7.723.6 32.5%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96419,453 5.0%   
Fx outflow Rs m6076,065 10.0%   
Net fx Rs m35713,388 2.7%   
CASH FLOW
From Operations Rs m1,3458,120 16.6%  
From Investments Rs m-2,256-7,556 29.9%  
From Financial Activity Rs m-1,200590 -203.2%  
Net Cashflow Rs m-2,1111,153 -183.0%  

Share Holding

Indian Promoters % 4.5 74.1 6.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 2.9 -  
FIIs % 1.4 9.1 14.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 13.9 677.0%  
Shareholders   20,807 49,328 42.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   DIVIS LABORATORIES  WOCKHARDT  VENUS REMEDIES  FRESENIUS KABI ONCO.  GLENMARK PHARMA  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex and Nifty Fell Over 1% Today(Closing)

Indian share markets witnessed heavy selling pressure today, pausing the record rally, with all sectors barring telecom, reeling under pressure.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Five Wishes and a Will(The Honest Truth)

Jan 4, 2021

Ajit Dayal on the investing strategy for 2021 and beyond.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS